Abbott Laboratories Inc.

Abbott Laboratories Inc. Abbott Vascular Inc. Division supplies cardiovascular medical devices, implantable cardiac systems, and diagnostic equipment to federal healthcare agencies as a prime contractor competing under full and open competition with no set-aside certifications. The division operates as a wholly owned business unit of Abbott Laboratories, a for-profit manufacturer of medical devices and related healthcare products headquartered in Abbott Park, Illinois, with Abbott Vascular Inc. maintaining operational facilities in Santa Clara, California.

Abbott Vascular's federal footprint centers overwhelmingly on the Department of Veterans Affairs and the Defense Logistics Agency's Medical Supply Chain. Across 11,364 total awards in the source dataset spanning more than two decades, Abbott Vascular holds a 100% prime contractor posture (11,349 prime awards versus 15 sub awards), indicating the division primes substantially all of its federal work and does not function as a routine subcontractor to other primes. The top five customer agencies by award count—VISN 8, VISN 2, VISN 15, VISN 7, and VISN 19—account for 29% of awards and are predominantly VA networks. However, customer concentration by dollar value diverges sharply: the Defense Logistics Agency Troop Support Medical dominates, representing 459 awards worth $241.7 million combined potential value (approximately 21% of the vendor's $1.17 billion total portfolio). The gap reflects Abbott Vascular's role as a high-volume, modest-value supplier to individual VA networks through purchase orders and delivery orders, contrasted with larger, more strategically valuable relationships at the DLA.

Abbott Vascular's concrete capability portfolio comprises stents, pacemakers (including leadless systems such as AVEIR), heart valves (transcatheter systems such as MitraClip), implantable cardiac monitors, left ventricular assist devices (LVAD), electrophysiology mapping and diagnostic systems (EnSite, Optis), and related surgical implants and accessories. Representative recent awards include a $439,615 firm fixed-price purchase order from VISN 17 in September 2025 for an EnSite X Electrophysiology System and accessories; a $195,959.81 delivery order from VISN 19 in August 2025 for CentriMag Support Equipment; a $560,000 firm fixed-price service agreement from VISN 9 awarded October 2025 for Abbott St. Jude EnSite System support through September 2030; and a $117.1 million Defense Logistics Agency indefinite delivery contract for comprehensive cardiovascular procedural packages (explicitly cited across numerous award summaries). The vendor holds four named Indefinite Delivery Contracts with VA networks: a $144,000 LVAD service plan with VISN 16 (through July 2030), a $500,000 Abbott Mitral Valve consignment contract with VISN 12 (through July 2030), a $1,132,650 transcatheter prosthetic surgical heart valve consignment with VISN 19 (through November 2029), and a $2-ceiling consignment heart valve contract with VISN 17 (through September 2029). Abbott Vascular also holds a position on the GSA Medical Equipment and Supplies Schedule (FSS-65-II-A), from which it has received task orders including a $24,723.62 CentriMag Blood Pumps delivery and a $195,959.81 CentriMag Support Equipment order.

Activity trajectory shows growth: awards per year climbed from 171 in 2022 to 306 in 2025, with 99 awards year-to-date in 2026 (representing a partial-year snapshot). Within the next twenty-four months, 27 awards carrying combined potential value of $4.8 million face ultimate completion and recompete exposure, representing modest churn relative to the vendor's overall portfolio. SCI-reported invoiced revenue totaled $39 thousand across FY2023–FY2024, derived from goods delivery rather than billable services; the vendor's federal revenue footprint is driven by product sales and delivery orders rather than labor-hour service contracts, consistent with its profile as a medical device manufacturer. The hourly rate posture captured in SCI shows government-paid rates around $802/hr (median), reflecting the limited service-contract activity in the dataset.

Abbott Vascular competes predominantly through full and open competition mechanisms; no awards carry small business set-aside designations. The vendor subcontracts minimally (0% of awards are sub positions). In its subcontractor role, Abbott Vascular delivers cardiovascular medical device components to Cardinal Health 200, LLC on discrete delivery orders (November 2025 and December 2024 awards for electrophysiology catheter kits and diagnostic catheters under the DLA Medical Supply Chain).

Abbott Vascular's federal customer concentration is characteristic of a mature, established vendor anchored to healthcare system procurement: the top five VA networks and the DLA Medical Supply Chain collectively represent the vast bulk of ordering activity. The vendor's category concentration aligns tightly with its core business—6,066 awards under Surgical and Medical Instrument Manufacturing (NAICS 339113) and 2,468 under Surgical Appliance and Supplies Manufacturing (NAICS 339115)—with 10,428 awards classified under PSC Medical and Surgical Instruments, Equipment, and Supplies. Abbott Vascular's strategic positioning as an essential supplier of life-critical cardiovascular implants and diagnostic systems to the VA and DoD healthcare infrastructure, combined with its established IDC vehicles and GSA Schedule seat, positions it as a routine procurement partner rather than a growth-stage or set-aside-dependent vendor.